Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
anagrelidhydroklorid 500 mikrogram, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
anagrelidhydroklorid 1 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely nimodipine 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Morphine sulfate 15 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely morphine sulfate 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
ampicillintrihydrat 250 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
ampicillintrihydrat 500 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Benzonatate 200 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely bexarotene 75 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Nortriptyline hydrochloride 50 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Minocycline hydrochloride 75 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely calcifediol 20 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely mexiletine hydrochloride 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely mexiletine hydrochloride 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Auranofin 3 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Hydroxycarbamide 200 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Hydroxycarbamide 300 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Hydroxycarbamide 400 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Hydroxyzine pamoate 25 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely hydroxyzine pamoate 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely mesuximide 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Cefdinir 300 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely nortriptyline hydrochloride 75 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Oxaprozin 600 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Nortriptyline hydrochloride 10 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely nortriptyline hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely mesuximide 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely methenamine hippurate 1 gram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Methyltestosterone 10 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
makrokristallin nitrofurantoin 25 mg, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
makrokristallin nitrofurantoin 50 mg, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
makrokristallin nitrofurantoin 100 mg, kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely methoxsalen 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely oxazepam 15 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely oxazepam 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Oxazepam 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
3 |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
3 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
3 |
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
3 |
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely nitrofurantoin macrocrystal 25 milligram and nitrofurantoin monohydrate 75 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely nitrofurantoin macrocrystal 25 milligram and nitrofurantoin monohydrate 75 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
amlodipinbesilat 2,5 milligram och benazeprilhydroklorid 10 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
amlodipinbesilat 2,5 milligram och benazeprilhydroklorid 10 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
amlodipinbesilat 5 milligram och benazeprilhydroklorid 10 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
amlodipinbesilat 5 milligram och benazeprilhydroklorid 10 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
amlodipinbesilat 5 milligram och benazeprilhydroklorid 20 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
amlodipinbesilat 5 milligram och benazeprilhydroklorid 20 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Amobarbital sodium 50 mg and secobarbital sodium 50 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Amobarbital sodium 50 mg and secobarbital sodium 50 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Nitisinone 2 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely nitisinone 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Nitisinone 10 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Amobarbital sodium 100 mg and secobarbital sodium 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Amobarbital sodium 100 mg and secobarbital sodium 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Nafcillin sodium 250 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Oxacillin sodium 250 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Oxacillin sodium 500 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Atomoxetine (as atomoxetine hydrochloride) 10 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 18 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Atomoxetine (as atomoxetine hydrochloride) 25 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely oseltamivir (as oseltamivir phosphate) 75 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely nabilone 2 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely nabilone 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Nabilone 250 microgram oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Miglustat 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
fluoxetinhydroklorid 25 milligram och olanzapin 6 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
fluoxetinhydroklorid 25 milligram och olanzapin 6 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
fluoxetinhydroklorid 50 milligram och olanzapin 6 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
fluoxetinhydroklorid 50 milligram och olanzapin 6 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
fluoxetinhydroklorid 25 milligram och olanzapin 12 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
fluoxetinhydroklorid 25 milligram och olanzapin 12 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
fluoxetinhydroklorid 50 milligram och olanzapin 12 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
fluoxetinhydroklorid 50 milligram och olanzapin 12 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely aprepitant 80 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Aprepitant 125 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely cevimeline 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |